Google DeepMind's AlphaGenome 2 Doubles Disease Variant Detection Across 28 Cell Types

Google DeepMind's AlphaGenome 2 is a conditional DNA model that predicts variant effects in individual cell types, doubling causal variant recall across 28 cell types and adapting to new single-cell data without retraining.

Read the full story at AlphaSignal ↗

Timeline · 1 report

2026-11-11 15:03 · AlphaSignal
Google DeepMind's AlphaGenome 2 Doubles Disease Variant Detection Across 28 Cell Types

More stories

Google DeepMind unveils AlphaGenome 2 to map how DNA changes affect cells — The Verge AI
Google DeepMind Unveils AlphaGenome 2 for Predicting Cell-State Variant Effects — Unite.AI
Google DeepMind launches Gemini Robotics 2.5, reports 96% success in Mercedes-Benz factory test — Google DeepMind Blog
Anthropic IPO said to be multiple times oversubscribed as it targets $1.4 trillion valuation — CNBC Technology
Google Labs launches Tabletop, a collaborative planning experiment — Google AI Blog
AlphaGenome 2: Predicting how DNA shapes cells and disease — Google DeepMind Blog
Meta and TikTok join Google in opposing Indonesia's proposed copyright law revisions — Reuters AI
Google launches Gemini 4 Carbon, its strongest model for agentic workflows — Google DeepMind Blog

Get the daily brief of stories like this at 6:30 every morning →